• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴基斯坦信德省乙型和丙型肝炎病毒感染流行率的变化:2007 年和 2019 年两次血清学调查的结果。

Changes in the prevalence of hepatitis B and C viral infections in Sindh province, Pakistan: Findings from two sero-surveys in 2007 and 2019.

机构信息

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

出版信息

J Viral Hepat. 2024 Nov;31(11):645-656. doi: 10.1111/jvh.13986. Epub 2024 Jul 26.

DOI:10.1111/jvh.13986
PMID:39056891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7617255/
Abstract

Pakistan harbours a large burden of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection. We utilised repeat sero-surveys to assess progress achieved towards hepatitis elimination in Pakistan. Multilevel logistic regression evaluated the change in HBV infection (HBV surface antigen (HBsAg)-positive) prevalence and HCV exposure (HCV antibody (HCV-Ab)-positive) prevalence between two sero-surveys from 2007 and 2019 for Sindh province and associated risk factors. Adjusted odds ratios (aORs) were estimated and population-attributable fractions (PAF) for modifiable risk factors for HCV exposure. The 2007 and 2019 surveys included 8855 and 6672 individuals. HBsAg prevalence decreased from 2.6% (95% confidence intervals (95% CI): 2.2-2.9) in 2007 to 1.1% (95% CI: 0.8-1.3) in 2019, while HCV-Ab prevalence increased from 5.1% (95% CI: 4.6%-5.5%) to 6.2% (95% CI: 5.6%-6.8%). The age and gender-adjusted HBsAg prevalence decreased by 80% (aOR = 0.2, 95% CI: 0.1-0.4) among children and 60% (aOR = 0.4, 95% CI: 0.3-0.6) among adults over 2007-2019, while HCV-Ab prevalence decreased by 60% (aOR = 0.4, 95%CI:0.2-0.7) in children and increased by 40% (aOR = 1.4, 95% CI: 1.2-1.7) in adults. HCV-Ab prevalence was lower in adults with secondary (aOR = 0.6, 95% CI: 0.5-0.8) and higher (aOR = 0.5, 95%CI:0.3-0.8) education compared to illiterates and higher among adults reporting blood transfusion (aOR = 1.7, 95% CI: 1.2-2.4), family history of hepatitis (aOR = 2.5, 95% CI: 1.9-3.3), past year medical injection (aOR = 2.1, 95% CI: 1.6-2.7), being tattooed (aOR = 1.4, 95% CI: 1.0-1.9) and shaved by traditional barber (aOR = 1.2, 95% CI: 1.0-1.5). Modifiable risk factors accounted for 45% of HCV exposure, with medical injection(s) accounting for 38% (95%CI,25.7-48.4%). Overall HCV has increased over 2007-2019 in Sindh province, while HBV prevalence has decreased. Medical injections should be an important focus of prevention activities.

摘要

巴基斯坦是乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)感染的重灾区。我们利用重复血清学调查来评估巴基斯坦在消除肝炎方面取得的进展。多水平逻辑回归评估了 2007 年和 2019 年两次血清学调查之间在信德省乙型肝炎感染(HBsAg 阳性)和丙型肝炎暴露(HCV-Ab 阳性)患病率的变化及其相关危险因素。估计了调整后的优势比(aOR)和丙型肝炎暴露的可改变危险因素的人群归因分数(PAF)。2007 年和 2019 年的调查分别包括 8855 人和 6672 人。HBsAg 患病率从 2007 年的 2.6%(95%置信区间(95%CI):2.2-2.9)下降到 2019 年的 1.1%(95%CI:0.8-1.3),而 HCV-Ab 患病率从 5.1%(95%CI:4.6%-5.5%)增加到 6.2%(95%CI:5.6%-6.8%)。2007 年至 2019 年期间,儿童的 HBsAg 年龄和性别调整后患病率下降了 80%(aOR=0.2,95%CI:0.1-0.4),成年人下降了 60%(aOR=0.4,95%CI:0.3-0.6),而儿童的 HCV-Ab 患病率下降了 60%(aOR=0.4,95%CI:0.2-0.7),成年人则增加了 40%(aOR=1.4,95%CI:1.2-1.7)。与文盲相比,具有中等(aOR=0.6,95%CI:0.5-0.8)和高等(aOR=0.5,95%CI:0.3-0.8)教育程度的成年人 HCV-Ab 患病率较低,而报告接受过输血(aOR=1.7,95%CI:1.2-2.4)、有肝炎家族史(aOR=2.5,95%CI:1.9-3.3)、过去一年接受过医疗注射(aOR=2.1,95%CI:1.6-2.7)、接受过纹身(aOR=1.4,95%CI:1.0-1.9)和传统理发师刮胡子(aOR=1.2,95%CI:1.0-1.5)的成年人 HCV-Ab 患病率较高。可改变的危险因素占 HCV 暴露的 45%,其中医疗注射占 38%(95%CI,25.7-48.4%)。总的来说,2007 年至 2019 年期间,信德省的 HCV 呈上升趋势,而 HBV 患病率则下降。医疗注射应该是预防活动的重点。

相似文献

1
Changes in the prevalence of hepatitis B and C viral infections in Sindh province, Pakistan: Findings from two sero-surveys in 2007 and 2019.巴基斯坦信德省乙型和丙型肝炎病毒感染流行率的变化:2007 年和 2019 年两次血清学调查的结果。
J Viral Hepat. 2024 Nov;31(11):645-656. doi: 10.1111/jvh.13986. Epub 2024 Jul 26.
2
Temporal trends in hepatitis B and C infection in family blood donors from interior Sindh, Pakistan.巴基斯坦信德省内陆地区家庭献血者中乙型和丙型肝炎感染的时间趋势。
BMC Infect Dis. 2008 Apr 10;8:43. doi: 10.1186/1471-2334-8-43.
3
Seroprevalence of hepatitis B and hepatitis C virus among clinically suspected cases of viral hepatitis visiting Guhalla Primary Hospital, Northwest Ethiopia.在埃塞俄比亚西北部的古哈拉初级医院就诊的疑似病毒性肝炎患者中乙型肝炎和丙型肝炎病毒的血清流行率。
Sci Rep. 2024 Sep 20;14(1):21956. doi: 10.1038/s41598-024-71363-w.
4
Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan.乙型和丙型肝炎:巴基斯坦卡拉奇儿童血清阳性率及其相关危险因素
BMC Infect Dis. 2006 Jun 23;6:101. doi: 10.1186/1471-2334-6-101.
5
Prevalence and associated risk factors for hepatitis B and C viruses among refugee populations living in Mahama, Rwanda: A cross-sectional study.卢旺达马哈马地区难民人群中乙型和丙型肝炎病毒的流行情况及其相关危险因素:一项横断面研究。
PLoS One. 2021 Oct 11;16(10):e0257917. doi: 10.1371/journal.pone.0257917. eCollection 2021.
6
Seroprevalence of HCV, HBV and HIV in two inner-city London emergency departments.在伦敦市内的两家急诊部门中丙型肝炎病毒、乙型肝炎病毒和艾滋病病毒的血清流行率。
Epidemiol Infect. 2019 Jan;147:e145. doi: 10.1017/S0950268819000360.
7
A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania.罗马尼亚中喀尔巴阡山脉和东南部地区 HBV、HCV、HDV 和 HEV 流行率的横断面流行病学研究。
J Gastrointestin Liver Dis. 2010 Mar;19(1):43-8. doi: 10.1007/s11749-009-0177-3.
8
Seroprevalence and associated risk factors of HBV and HCV infections in the population of Ghudduwah Village, South Libya.利比亚南部古杜瓦村人群中乙肝病毒和丙肝病毒感染的血清流行率及相关危险因素
J Infect Dev Ctries. 2025 Jan 31;19(1):117-123. doi: 10.3855/jidc.20088.
9
Seroprevalence of hepatitis B virus and hepatitis C virus co-infection among people living with HIV/AIDS visiting antiretroviral therapy centres in Nepal: a first nationally representative study.尼泊尔接受抗逆转录病毒治疗的艾滋病毒/艾滋病患者中乙型肝炎病毒和丙型肝炎病毒合并感染的血清流行率:一项全国性的首次代表性研究。
Int J Infect Dis. 2017 Jul;60:64-69. doi: 10.1016/j.ijid.2017.04.011. Epub 2017 May 5.
10
Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh.孟加拉国达卡一个贫困城市社区的乙型和丙型肝炎病毒感染的流行情况和危险因素。
BMC Infect Dis. 2010 Jul 15;10:208. doi: 10.1186/1471-2334-10-208.

引用本文的文献

1
Hepatitis C virus cascade of care among adults in Sindh province, Pakistan: Findings from 2019-2020 household sero-survey.巴基斯坦信德省成年人丙型肝炎病毒照护流程:2019 - 2020年家庭血清学调查结果
PLOS Glob Public Health. 2025 Jul 8;5(7):e0004706. doi: 10.1371/journal.pgph.0004706. eCollection 2025.
2
Hepatitis C virus transmission among people who inject drugs in the Middle East and North Africa: mathematical modeling analyses of incidence and intervention impact.中东和北非地区注射吸毒人群中的丙型肝炎病毒传播:发病率及干预影响的数学建模分析
EClinicalMedicine. 2025 Jan 15;80:103040. doi: 10.1016/j.eclinm.2024.103040. eCollection 2025 Feb.

本文引用的文献

1
Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.注射吸毒的流行病学、与注射相关的危害的流行率,以及注射吸毒者的行为和环境风险的暴露情况:系统评价。
Lancet Glob Health. 2023 May;11(5):e659-e672. doi: 10.1016/S2214-109X(23)00057-8. Epub 2023 Mar 27.
2
The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agenda.被遗忘的人群:乙型肝炎病毒 (HBV) 感染作为纳入卫生议程的优先事项。
Elife. 2023 Feb 9;12:e81070. doi: 10.7554/eLife.81070.
3
Hepatitis B Prevalence and Risk Factors in Punjab, India: A Population-Based Serosurvey.印度旁遮普邦的乙肝流行情况及风险因素:一项基于人群的血清学调查
J Clin Exp Hepatol. 2022 Sep-Oct;12(5):1310-1319. doi: 10.1016/j.jceh.2022.04.014. Epub 2022 Apr 18.
4
Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家乙型肝炎负担,1990-2019 年:基于 2019 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2022 Sep;7(9):796-829. doi: 10.1016/S2468-1253(22)00124-8. Epub 2022 Jun 21.
5
New WHO guidance for country validation of viral hepatitis B and C elimination.世界卫生组织关于国家验证消除乙型和丙型病毒性肝炎的新指南。
Lancet Gastroenterol Hepatol. 2021 Oct;6(10):778-780. doi: 10.1016/S2468-1253(21)00267-3. Epub 2021 Aug 9.
6
Prevalence and Risk Factors Associated with Hepatitis B and C in Nawabshah, Sindh, Pakistan.巴基斯坦信德省瑙什拉市乙型和丙型肝炎的流行情况及相关危险因素。
Am J Trop Med Hyg. 2020 Dec 21;104(3):1101-1105. doi: 10.4269/ajtmh.20-1228.
7
Analytical performance of eight rapid point-of-care tests routinely used for the detection of HBsAg in Burkina Faso: A cross-sectional study.在布基纳法索,对常规用于检测 HBsAg 的八种即时检验的分析性能评估:一项横断面研究。
J Clin Virol. 2020 Aug;129:104546. doi: 10.1016/j.jcv.2020.104546. Epub 2020 Jul 7.
8
Injection practices in 2011-2015: a review using data from the demographic and health surveys (DHS).2011-2015 年的注射实践:利用人口与健康调查(DHS)数据进行的回顾。
BMC Health Serv Res. 2019 Aug 27;19(1):600. doi: 10.1186/s12913-019-4366-9.
9
Treatment as prevention for hepatitis C virus in Pakistan: mathematical modelling projections.巴基斯坦丙型肝炎病毒治疗即预防:数学建模预测。
BMJ Open. 2019 May 27;9(5):e026600. doi: 10.1136/bmjopen-2018-026600.
10
Analytical performance of newly developed rapid point-of-care test for the simultaneous detection of hepatitis A, B, and C viruses in serum samples.新型即时检验用于血清样本中同时检测甲型、乙型和丙型肝炎病毒的分析性能评估。
J Med Virol. 2019 Jun;91(6):1056-1062. doi: 10.1002/jmv.25405. Epub 2019 Jan 30.